HepeX-B

· Cubist Pharmaceuticals LLC (subsidiary of Merck & Co., Inc.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HepeX-B, covering 2007-02-13 to 2007-02-13. Get the full timeline:

Most recent: Clinical Trial Update: HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection [Phase 2]

See pricing